Mechanisms that control the levels and activities of reactive oxygen species (ROS) in normal human mammary cells are poorly understood. We show that purified normal human basal mammary epithelial cells maintain low levels of ROS primarily by a glutathione-dependent but inefficient antioxidant mechanism that uses mitochondrial glutathione peroxidase 2. In contrast, the matching purified luminal progenitor cells contain higher levels of ROS, multiple glutathione-independent antioxidants and oxidative nucleotide damage-controlling proteins and consume O 2 at a higher rate. The luminal progenitor cells are more resistant to glutathione depletion than the basal cells, including those with in vivo and in vitro proliferation and differentiation activity. The luminal progenitors also are more resistant to H 2 O 2 or ionizing radiation. Importantly, even freshly isolated "steady-state" normal luminal progenitors show elevated levels of unrepaired oxidative DNA damage. Distinct ROS control mechanisms operating in different subsets of normal human mammary cells could have differentiation state-specific functions and long-term consequences.
Glutathione-dependent and -independent oxidative stress-control mechanisms distinguish normal human mammary epithelial cell subsets Mechanisms that control the levels and activities of reactive oxygen species (ROS) in normal human mammary cells are poorly understood. We show that purified normal human basal mammary epithelial cells maintain low levels of ROS primarily by a glutathione-dependent but inefficient antioxidant mechanism that uses mitochondrial glutathione peroxidase 2. In contrast, the matching purified luminal progenitor cells contain higher levels of ROS, multiple glutathione-independent antioxidants and oxidative nucleotide damage-controlling proteins and consume O 2 at a higher rate. The luminal progenitor cells are more resistant to glutathione depletion than the basal cells, including those with in vivo and in vitro proliferation and differentiation activity. The luminal progenitors also are more resistant to H 2 O 2 or ionizing radiation. Importantly, even freshly isolated "steady-state" normal luminal progenitors show elevated levels of unrepaired oxidative DNA damage. Distinct ROS control mechanisms operating in different subsets of normal human mammary cells could have differentiation state-specific functions and long-term consequences.
human epithelial stem and progenitor cells | mammary differentiation | 3D clonogenic assay | superoxide dismutase | peroxiredoxin C ellular synthesis of different reactive oxygen species (ROS) results primarily from the incomplete reduction of molecular oxygen in mitochondria to generate free radical superoxide anions. ROS also are produced when cells are exposed to different environmental sources of oxidative stressors, including ionizing radiation. Together, these regulate many normal cellular processes and also contribute to DNA damage, tumorigenesis, and cell death (1) (2) (3) .
In mice, the inner layer of "luminal" epithelial cells of the normal adult mammary gland have been found to contain higher levels of ROS than the outer "basal" layer of epithelial cells (4) . The basis for these differences in ROS levels in the two cell types has been attributed to differences in their content of mitochondria; however, their stress response mechanisms have not been defined. Even less is known about ROS levels and their control in the normal adult human mammary gland, which consists of a similar continuous bilayered epithelial network of ducts and terminal alveolae. MCF10A cells are an immortal but nontumorigenic human mammary cell line that, when grown in 3D Matrigel cultures, generates multilayered spheres in which a lumen forms owing to the acquisition of lethal levels of ROS by the inner cells (5) . These studies have suggested that ROS regulation plays an important role in the structural morphogenesis and homeostasis of normal adult human mammary tissue.
Here we report the results of experiments designed to investigate the levels of ROS and their control in highly purified populations of viable luminal progenitors (LPs) and basal cells (BCs) isolated from normal human breast tissue (6) (7) (8) 
MUC1
+ LPs were purified by fluorescence-activated cell sorting (FACS) at ≥98% purity from normal human reduction mammoplasty samples depleted of hematopoietic cells, endothelial cells, and stromal cells (SCs) ( Fig. 1 A and B) . These LP and BC subsets were highly enriched in cells with lineage-restricted and bilineage clonogenic activity in vitro, respectively (∼20%; Fig. S1A ). Some BCs can also regenerate complete bilayered gland structures containing clonogenic progeny in xenotransplanted immunodeficient mice (8, 9) . The inner luminal epithelial layer of the normal human mammary gland also contains many cells devoid of clonogenic activity. These cells, known as luminal cells (LCs), can be isolated as a phenotypically distinct population based on their lack of CD49f and CD90(THY1) expression and high EpCAM and MUC1 expression. LPs are thus assumed to represent an intermediate stage of differentiation between BCs and LCs.
FACS analysis of dihydroethidium (DHE)-stained cells showed a higher free-radical superoxide anion (O 2°) content in the purified LPs compared with the purified BCs (Fig. 1C ). Parallel measurements of intracellular H 2 O 2 , generally assumed to be the major intracellular nonradical ROS produced by
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Our study reveals lineage-specific mechanisms of ROS control and associated sensitivity to oxidative DNA damage in the basal and luminal progenitor-enriched subsets of normal human mammary cells. We show that the primitive luminal cells contain more mitochondria, show greater uptake of O 2 , sustain and withstand higher levels of ROS, and have mechanisms that allow them to accrue mutagenic levels of oxidative DNA damage. These findings support a growing body of data suggesting the involvement of primitive luminal cells in the generation of human breast cancers.
spontaneous or catalyzed dismutation of mitochondrial O 2°, revealed higher levels in the LPs (Fig. 1D) . The higher ROS in LPs is consistent with the higher number of mitochondria that they contain, as indicated by their higher levels of mitochondrial-specific β-F1-ATPase seen on Western blot analysis (Fig. 1E ), higher levels of mitochondrial-specific DNA on quantitative RT-PCR (qRT-PCR) analysis (Fig. 1F) , and more intense fluorescence when stained with MitoTracker dye (Fig. 1G) . The LPs also showed greater sequestration of the tetramethylrhodamine ethyl ester (TMRE) dye (Fig. 1H ) and more rapid O 2 consumption (Fig. 1I) , indicative of increased mitochondrial activity in the LPs.
Different Antioxidant Mechanisms Are Active in Different Subsets of
Normal Human Mammary Cells. We next asked whether the different subsets of normal human mammary cells would show differences in the mechanisms used to produce and control ROS. We first compared the levels of SOD1, SOD2, and SOD3 present in FACS-purified BCs, LPs, and LCs, because these three enzymes act spatially to maintain steady-state concentrations of O 2°t hrough conversion to H 2 O 2 (10) . Western blot analysis showed consistent elevations of all three SODs in both LPs and LCs compared with BCs, in agreement with the finding that the total SOD activity in LPs was higher than in the BCs (Fig. 2 A and B) . We also investigated the levels of both glutathione-dependent and glutathione-independent enzymes that reduce intracellular H 2 O 2 . The former included the glutathione peroxidases (GPX) 1-8 and 1-cysteine peroxiredoxinperoxidase (PRDX) 6, and the latter included catalase and 2-cysteine peroxiredoxin-peroxidases, PRDX1-5 (11, 12) . Western blot analyses revealed higher levels of many of the antioxidantperoxidases in the LPs and LCs compared with the BCs (Fig.  2A) , consistent with the increased total GPX activity detected in LPs compared with BCs (Fig. 2C) .
Biochemical determination of intracellular levels of NAD(P)H, the ultimate electron donor for antioxidant mechanisms (13) showed higher levels in LPs (Fig. 2D) . Transcript levels for the catalytic subunit of γ-glutamyl-cysteinyl ligase (GCLC), a ratelimiting enzyme in glutathione biosynthesis (14) , also were higher in LPs (Fig. 2E ). Elevated glutathione levels in LPs were confirmed by FACS-based measurement of monochlorobimanestained cells (Fig. 2F ). Taken together, these findings indicate that the LPs in the normal human mammary gland have a stronger antioxidant defense profile than the BCs.
In contrast, both qRT-PCR and Western blot analyses showed that the mitochondrial enzyme glutathione peroxidase 2 (GPX2) is present almost exclusively in BCs (Fig. 2 A and G), as suggested by previous serial analyses of gene expression and microarray analyses of their transcript levels ( Fig. S2A) (7) . On Western blot analysis, GPX2 was largely undetectable in either luminal subset or in the SCs (Fig. S2B) . Interestingly, BCs consistently showed higher transcript levels of the antioxidant transcription factor NRF2 and its response element, γ-glutamylcysteinyl ligase modulatory subunit (GCLM) (Fig. 2E ). These observations suggest that the BCs of the normal human mammary gland may rely primarily on their lower, albeit tightly regulated, glutathione levels and GPX2 to deal with the lower levels of ROS that they produce compared with the LPs and LCs. In contrast, the latter make use of different, more effective mechanisms to survive the higher levels of ROS that they sustain.
Differing Effects of Perturbing Endogenous Control of Oxidative
Stress in Different Subsets of Normal Human Mammary Cells. To test these predictions, we first compared the effect of lowering the level of intracellular glutathione on the proliferative activity of BCs and LPs by adding buthionine sulfoximine (BSO), a potent and selective inhibitor of glutathione synthesis (15) , or vehicle directly into the media in which the cells were assayed ( Fig. 3A and Fig. S1B ). BSO concentrations that had little or no effect on LPs markedly, selectively, and specifically reduced the yield from BCs of total viable cells in 4-d bulk cultures (Fig. 3B ) and of colonies produced in either 2D (at 20% O 2 ) or 3D (at 5% O 2 ) 10-d cultures (Fig. 3 C-F) . However, the addition of either N-acetyl cysteine (NAC) or Trolox completely reversed the toxic effect of BSO on the BCs and had no effect on the LPs (Fig. 3C) .
We also tested the effect of pretreating purified BCs and LPs with BSO for 2 d in vitro (under 2D conditions) on their subsequent clonogenic activity assessed either immediately, in the absence of BSO, or, in the case of the BCs only, at 4 wk after being transplanted under the kidney capsules of immunodeficient mice (Fig. 3G) . The results showed that BCs with both in vivo and in vitro proliferative activity are highly sensitive to even short-term exposure to BSO (Fig. 3H) .
As an alternative approach, we depleted GPX2 by transducing bulk normal human mammary cells with a lentivirus encoding a reporter fluorescent protein (VENUS) with or without a shRNA directed against GPX2 transcripts (shRNA GPX2) (Fig. 3I) and then compared the numbers of colonies obtained from the transduced (VENUS + ) cells (Fig. 3J) . The results of these experiments also showed a much greater shRNA GPX2-mediated reduction of colony yields from the BCs compared with the LPs.
These findings indicate that the more primitive human mammary BCs are much more reliant on glutathione-dependent mechanisms to survive even the relatively low levels of ROS that they possess. In contrast, the LPs' multiple glutathioneindependent antioxidant mechanisms appear sufficient to ensure their survival and clonogenic activity despite their much higher ROS levels.
Differing Effects of Exogenously Derived Oxidative Stress on Different
Subsets of Normal Human Mammary Cells. To test the possibility that LPs might also be more resistant to perturbations that increase their intracellular ROS levels, we next compared the effect of increasing concentrations of H 2 O 2 on the viable cell output of purified BCs and LPs in 4-d bulk cultures and on their clonogenic activities in both 2D and 3D assays (Fig. 4 A-D) . Compared with the BCs, the LPs were more resistant to H 2 O 2 exposure in all three assays. Despite this differential toxicity, the differentiated features of the 10-d progeny of the H 2 O 2 -treated cells were unchanged compared with untreated controls (Fig.  S3 ). In addition, the selective H 2 O 2 toxicity in BCs was partially neutralized by pretreatment of BCs with NAC or Trolox (Fig. 4C) .
Ionizing radiation also mediates its lethal effects primarily by producing intracellular ROS, which then cause double-strand breaks in the DNA (16) . Responses of mammary cells to ionizing radiation are of particular interest, because this treatment remains a current mainstay in the management of breast cancer. Comparing the effect of increasing X-ray doses on the subsequent clonogenic activity of BCs and LPs (in 2D assays) revealed that the LPs were again more resistant (Fig. 4E) . Interestingly, LPs also expressed higher levels of OGG1, MTH1 (also known as NUDT1), and MUTYH(MYH) (Fig. 4F and Fig.  S4 ), enzymes that promote cell survival by reducing the toxic, oxidized nucleotides generated by ROS from free intracellular pools or that have been incorporated into cellular DNA (17-19) . 
(D) NAD(P)
H levels in extracts of equal numbers of BCs and LPs, determined from paired samples by spectrophotometry using the Biovision kit. n = 3; P = 0.01. (E) Fold increase in qRT-PCR-determined transcript levels of the catalytic subunit of GCL (GCLC; n = 10; P < 0.05), its modulatory subunit (GCLM; n = 10; P < 0.0001), and transcription factor Nuclear Factor (Erythroid-Derived 2)-Like 2 (NRF2; n = 8; P < 0.001) in LPs compared with matched BCs. (F) Representative FACS histograms of monochlorobimane-stained BCs and LPs showing their different intracellular reduced-glutathione levels and the fold increase in MFI of LPs vs. matching BCs. n = 7; P < 0.0005. (G) Comparison of qRT-PCR-determined transcript levels of GPX2 (n = 9; P < 0.005) and TP63 (n = 8; P < 0.01) in BCs and LPs.
Given the elevated levels of intracellular ROS characteristic of LPs, along with the long-established association between chronic oxidative stress and oxidative damage to DNA, we then asked whether the LPs would exhibit evidence of oxidative DNA damage even without treatments designed to alter their ROS levels. H 2 O 2 in the presence of transition metal ions, such as iron or copper, is known to cause oxidative damage to DNA via Fenton's reaction, which generates short-lived hydroxyl radicals (OH°) continuously at low levels in living cells (20) . One indicator of such oxidative damage is the formation of genomic 8-oxo-deoxyguanosine (8-oxo-dG) nucleotides (21) (22) (23) . FACS measurement of genomic 8-oxo-dG levels in the DNA from purified LPs and BCs revealed higher levels in the LPs (Fig. 4G) . Thus, LPs that survive oxidative insults presumably continue to accumulate additional oxidative DNA damage (Fig. 4H) .
Discussion
Delineating homeostatic ROS control mechanisms in human mammary BCs and luminal epithelial cells may provide new insights relevant to both normal and malignant breast tissue. Our findings establish the normal human luminal epithelium as a distinct site of oxidative stress resistance in the presence of high intracellular ROS levels mediated by a unique enzymatic repertoire. These features distinguish LPs from BCs, which include very primitive bipotent cells with both luminal and myoepithelial differentiation abilities (24) . The unique properties of the LPs include up-regulated levels and activity of SODs and their superoxide substrates, with an accompanying switch in mechanisms used to control ROS levels and promote cell survival in the presence of increased ROS levels. Specifically, this "switch" involves the replacement of a highly glutathione-dependent mechanism primarily mediated by GPX2 in the BCs with a largely glutathione-independent mechanism in the LPs.
It is important to note that the observations made here are for cells obtained from "resting" normal adult human mammary glands. Exmaining whether different results will be found for mammary cells subject to the strong hormonal influences of pregnancy and initiation or cessation of lactation will be of interest. The present findings also set the stage for future investigations of the transcriptional regulation of the switch in ROS control that demarcates the generation of LPs from BCs. Various transcription factors show dramatic differences in expression in these two subsets, of which TP63, NOTCH3, and GATA3 are notable examples (7, 9, 25, 26) . Of these, TP63 has been reported to increase the tolerance of breast cancer cells to oxidative stress by transactivating GPX2 (27) . It is also possible that the glutathione-independent and oxidative DNA damage control mechanisms that confer resistance to oxidative stress described here as characteristic of normal LPs and LCs may operate in their malignant derivatives, making them more resistant to oxidative treatments. The glutathione-independence of the LPs and their more differentiated LC progeny is associated with up-regulated expression of numerous enzymes that, in combination, appear able to counteract at least some of the potentially lethally mutagenic effects of the ROS levels that these cells produce. These observations add to a growing body of data revealing other mechanisms that predispose normal human luminal cells to DNA damage (28) . Thus, the up-regulated expression of multiple antioxidant enzymes at the point of mammary progenitor cell restriction to the luminal lineage could contribute to multiple mechanisms that promote the death of LCs and allow lumen formation (5) . Consistent with this hypothesis is our present finding of increased expression in LPs and LCs of unique PRDXperoxidases that facilitate a type of "floodgate" control of ROS levels owing to these enzymes' innate capability to be inactivated selectively in response to various stimuli (29, 30) .
Materials and Methods
Cells. Histologically confirmed normal anonymized tissue from women undergoing cosmetic reduction mammoplasty was obtained following procedures approved by the University of British Columbia's Ethics Review Board.
Tissue was processed and viable single cells were isolated as described previously (31) . In brief, reduction tissues were first minced with a scalpel and dissociated in Ham's F-12 medium and DMEM (1:1 vol/vol; Stem Cell Technologies) supplemented with 2% wt/vol BSA (Fraction V; Life Technologies), 300 U/mL collagenase (Sigma-Aldrich), and 100 U/mL hyaluronidase (SigmaAldrich), from which an epithelial organoid-rich pellet was obtained after centrifugation at 80 × g for 4 min. Single-cell suspensions were then obtained after further incubation in 1 mM EDTA supplemented with 2.5 mg/mL trypsin (Stem Cell Technologies), 5 mg/mL dispase (Stem Cell Technologies), and 100 μg/mL DNase1 (Sigma-Aldrich), followed by filtration of the suspension through a 40-μm strainer. Mammary cells were then stained with antibodies listed in Table S1 , and subsets were isolated as described previously (7, 8) , using a protocol in which hematopoietic and endothelial cells were removed using fluorochrome-conjugated antibodies to CD45 and CD31, respectively. Cells were also stained with DAPI to eliminate dead (DAPI + ) cells. SCs were eliminated based on absent or reduced expression of EpCAM and/ or CD49f. Viable subsets of epithelial cells were then isolated at ≥98% purity using a FACSAria or Influx II cell sorter (BD Biosciences), as described in Fig. 1 A and B .
In Vitro and in Vivo Growth Assays. Bulk cultures for toxicity experiments were initiated by seeding 5,000 purified BCs and LPs on collagen-coated wells in 96-well plates in SF7 media supplemented with 5% FBS, followed by colorimetric assessment for viable cells after a 4-h incubation with 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT), as described previously (32) . The 2D and 3D clonogenic assays were performed as described in Fig. S1 . Intracellular Flow Cytometry. For live-cell analyses, cells were either costained with antibodies to allow the isolation of subsets or were first purified and then incubated for 30 min at 37°C with 100 nM MitoTracker, 10 μM DCFDA, 5 μM dihydroethidium, 400 nM TMRE (all from Invitrogen), or 50 μM monochlorobimane (Sigma-Aldrich). For the detection of 8-oxo-dG DNA adducts, FACS-purified cells were secondarily fixed, permeabilized, and then stained with a specific Calbiochem 8-oxo-dG-binding FITC probe (EMD Millipore). Stained cells were analyzed using a FACSAria, FACSInfluxII, or Fortessa machine (BD Biosciences Antioxidant Activity Assays. A total SOD activity kit (Enzo Life Sciences) and total glutathione peroxidase activity kit (Cedarlane) were used to measure respective antioxidant activities in purified cells.
NAD(P)H Levels. NAD(P)H was measured on lysed aliquots of 10 5 FACS-purified cells using a commercially available kit (BioVision Research Products).
qRT-PCR and Western Blot Analyses. Cells were rapidly lysed for RNA and protein isolation and analyzed by standard methods (33) . The antibodies and primers used are listed in Tables S1 and S2 , respectively.
Lentiviral Transduction. A human GPX2 targeting shRNA (Open Biosystems) was cloned into the pLKO.1-VENUS lentiviral vector, and virus-containing supernatants were generated and used to infect test cells as described previously (7) . Transduced (VENUS + ) cells were isolated 2-3 d later and assayed for colony formation. The shRNA activity of the lenticonstruct was confirmed by Western blot analyses of GPX2 levels in extracts of transduced human hepatocarcinoma HepG2 cells cultured for 2-3 d before isolation of the transduced (VENUS + ) cells.
Graphs and Statistics. GraphPad Prism 6 software was used for statistical comparisons and graph generation. Values are reported as mean ± SEM, and P values were generated using the Student t test. The number of independent experiments with cells from different donors is shown in brackets.
